AU2785699A - Method and compositions for differential detection of primary tumor cells and metastatic cells - Google Patents

Method and compositions for differential detection of primary tumor cells and metastatic cells

Info

Publication number
AU2785699A
AU2785699A AU27856/99A AU2785699A AU2785699A AU 2785699 A AU2785699 A AU 2785699A AU 27856/99 A AU27856/99 A AU 27856/99A AU 2785699 A AU2785699 A AU 2785699A AU 2785699 A AU2785699 A AU 2785699A
Authority
AU
Australia
Prior art keywords
cells
compositions
primary tumor
differential detection
tumor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27856/99A
Inventor
Emilio Barbera-Guillem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLI Oncology Inc
Original Assignee
CLI Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLI Oncology Inc filed Critical CLI Oncology Inc
Publication of AU2785699A publication Critical patent/AU2785699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/55—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU27856/99A 1998-02-27 1999-02-24 Method and compositions for differential detection of primary tumor cells and metastatic cells Abandoned AU2785699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3204898A 1998-02-27 1998-02-27
US09032048 1998-02-27
PCT/US1999/004005 WO1999044064A1 (en) 1998-02-27 1999-02-24 Method and compositions for differential detection of primary tumor cells and metastatic cells

Publications (1)

Publication Number Publication Date
AU2785699A true AU2785699A (en) 1999-09-15

Family

ID=21862819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27856/99A Abandoned AU2785699A (en) 1998-02-27 1999-02-24 Method and compositions for differential detection of primary tumor cells and metastatic cells

Country Status (3)

Country Link
AU (1) AU2785699A (en)
CA (1) CA2322282A1 (en)
WO (1) WO1999044064A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
CA2466896A1 (en) 2001-09-06 2003-03-20 Adnagen Ag Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
EP1409745B1 (en) * 2001-09-06 2007-04-11 Adnagen AG Method and kit for the diagnosis or treatment control of intestinal carcinoma
EP1409746A2 (en) * 2001-09-06 2004-04-21 Adnagen AG Method and kit for diagnosing or controlling the treatment of breast cancer
US7318902B2 (en) 2002-02-04 2008-01-15 Colorado School Of Mines Laminar flow-based separations of colloidal and cellular particles
CA2500392C (en) 2002-09-27 2012-11-27 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US9878326B2 (en) 2007-09-26 2018-01-30 Colorado School Of Mines Fiber-focused diode-bar optical trapping for microfluidic manipulation
US9885644B2 (en) 2006-01-10 2018-02-06 Colorado School Of Mines Dynamic viscoelasticity as a rapid single-cell biomarker
US9487812B2 (en) 2012-02-17 2016-11-08 Colorado School Of Mines Optical alignment deformation spectroscopy
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US10722250B2 (en) 2007-09-04 2020-07-28 Colorado School Of Mines Magnetic-field driven colloidal microbots, methods for forming and using the same
EP3751005A3 (en) 2008-09-20 2021-02-24 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4727020A (en) * 1985-02-25 1988-02-23 Becton, Dickinson And Company Method for analysis of subpopulations of blood cells
WO1994020120A1 (en) * 1993-03-12 1994-09-15 Cellcor, Inc. In vitro assay measuring degree of activation of immune cells
US5536642A (en) * 1993-09-09 1996-07-16 Barbera-Guillem; Emilio Diagnostic and prognostic methods for solid non-lymphoid tumors and their metastases

Also Published As

Publication number Publication date
CA2322282A1 (en) 1999-09-02
WO1999044064A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
AU2785699A (en) Method and compositions for differential detection of primary tumor cells and metastatic cells
AU1610299A (en) Method of cancer cell detection
AU3116800A (en) Compositions and methods for altering cell migration
AU3785699A (en) Chip stack and method of making same
EP1062507B8 (en) Determination of white blood cell differential
AU1603199A (en) Methods and devices for measuring differential gene expression
MXPA01006099A (en) Methods and compositions for reducing the permeabilities of subterranean zones.
AU5788401A (en) Method of detecting cancerous lesions
AU5202499A (en) Fuel cell tubes and method of making same
AU6958498A (en) Method for detection of recurrent prostate cancer
AU2637299A (en) Method and kit for the detection of explosives
AU3105700A (en) Methods for detection of antiestrogen-resistant breast cancer
AU1204299A (en) Trench ic and method of making
AU7358298A (en) Method of detecting metastatic thyroid cancer
AU6136999A (en) Method and system for improved detection of prostate cancer
AUPP278698A0 (en) Method of cell nuclei segmentation
AU3516899A (en) Method and probes for the detection of chromosome aberrations
ZA200006300B (en) Composition comprising tumor cells and extracts and method of using thereof.
AU6270799A (en) Firestarter and method of making same
AU2674399A (en) Compositions and methods for the inhibition of muc-5 mucin gene expression
AU5773999A (en) Radioactive seed and method of making
AU4150999A (en) Method and kit for early diagnosis of cancer
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU1110799A (en) Method of inhibiting metastases of cancer cells
AU1744600A (en) Detection of t cell stimulating tumor antigens

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase